NC false 0000818479 0000818479 2021-01-04 2021-01-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

January 4, 2021

Date of Report (date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware |  | 0-16211 |  | 39-1434669
(State or other jurisdiction of incorporation or organization) |  | (Commission File Number) |  | (I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place, Charlotte North Carolina |  | 28277-3607
(Address of Principal Executive Offices) |  | (Zip Code)

(844) 848-0137

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, par value $0.01 per share |  | XRAY |  | The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 | Entry into a Material Definitive Agreement.

On December 31, 2020, DENTSPLY SIRONA Inc. (the “Company”) entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Straight Smile, LLC, a Delaware limited liability company (“Straight Smile”), the members of Straight Smile (the “Straight Smile Members”) and Member Representative SSB, LLC, a Wyoming limited liability company, in its capacity as the Equityholder Representative, pursuant to which the Company acquired 100% of the outstanding membership interest of Straight Smile (the “Transaction”).

Pursuant to the terms of the Purchase Agreement, the Company paid $1,040,000,000 in cash, as consideration to the Straight Smile Members in exchange for the sale of their membership units, payable at the closing of the transactions contemplated by the Purchase Agreement, subject to customary adjustments for indebtedness (net of cash), transaction expenses and changes to working capital.

The Purchase Agreement contains customary representations and warranties and covenants of each of the parties and related indemnification obligations.

The Transaction closed on December 31, 2020.

The foregoing description of the Purchase Agreement and the transactions contemplated thereby is not complete and is subject to and qualified in its entirety by reference to the Purchase Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K, the terms of which are incorporated herein by reference.

The Purchase Agreement is attached as Exhibit 2.1 in accordance with the rules of the Securities and Exchange Commission. It is not intended to provide any financial or other information about Straight Smile, the Company or their respective subsidiaries and affiliates. In particular, the assertions embodied in the representations and warranties contained in the Purchase Agreement are qualified by information in confidential disclosure schedules provided by each party in connection with the signing of the Purchase Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the Purchase Agreement. Moreover, certain representations and warranties in the Purchase Agreement were used for the purpose of allocating risk between the parties rather than establishing certain matters as facts. The Company’s investors and security holders should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition of Straight Smile, the Company or any of their respective subsidiaries or affiliates.

Item 8.01 | Other Information.

On January 4, 2021, the Company issued a press release announcing the execution of the Purchase Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

In addition, on January 4, 2021, the Company provided supplemental information regarding the transaction in connection with presentations to analysts and investors. A copy of the investor presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference.

The information furnished in Item 8.01 to this Form 8-K, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 | Financial Statements and Exhibits.

(d) | Exhibits

Exhibit No. |  | Description
2.1 |  | Equity Purchase Agreement, dated as of December 31, 2020, by and among Dentsply Sirona Inc., Straight Smile, LLC, the members of Straight Smile, LLC and Member Representative SSB, LLC
99.1 |  | DENTSPLY SIRONA Inc. press release, dated January 4, 2021
99.2 |  | Investor Presentation, dated January 4, 2021
104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  |  |  | DENTSPLY SIRONA Inc.
Date: January 4, 2021 |  |  |  | By: |  | /s/ Keith J. Ebling
|  |  |  |  |  | Keith J. Ebling, Executive Vice President,
|  |  |  |  |  | General Counsel and Secretary